HK1243924A1 - 用於治療炎症病理的脂肪酸(f.a.g.，脂肪酸族)混合物 - Google Patents

用於治療炎症病理的脂肪酸(f.a.g.，脂肪酸族)混合物

Info

Publication number
HK1243924A1
HK1243924A1 HK18103386.6A HK18103386A HK1243924A1 HK 1243924 A1 HK1243924 A1 HK 1243924A1 HK 18103386 A HK18103386 A HK 18103386A HK 1243924 A1 HK1243924 A1 HK 1243924A1
Authority
HK
Hong Kong
Prior art keywords
fatty acids
mixture
treatment
inflammatory pathologies
group
Prior art date
Application number
HK18103386.6A
Other languages
English (en)
Inventor
Lodovico Burattin
Original Assignee
Again Life Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48227394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1243924(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Again Life Italia Srl filed Critical Again Life Italia Srl
Publication of HK1243924A1 publication Critical patent/HK1243924A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK18103386.6A 2013-03-08 2018-03-12 用於治療炎症病理的脂肪酸(f.a.g.，脂肪酸族)混合物 HK1243924A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361774796P 2013-03-08 2013-03-08
IT000354A ITMI20130354A1 (it) 2013-03-08 2013-03-08 Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

Publications (1)

Publication Number Publication Date
HK1243924A1 true HK1243924A1 (zh) 2018-07-27

Family

ID=48227394

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18103386.6A HK1243924A1 (zh) 2013-03-08 2018-03-12 用於治療炎症病理的脂肪酸(f.a.g.，脂肪酸族)混合物

Country Status (18)

Country Link
US (2) US11020365B2 (zh)
EP (2) EP3219316B1 (zh)
AU (2) AU2014224710B2 (zh)
CA (1) CA2904112C (zh)
CY (2) CY1122248T1 (zh)
DK (2) DK2964215T3 (zh)
EA (2) EA036724B1 (zh)
ES (2) ES2779851T3 (zh)
HK (1) HK1243924A1 (zh)
HR (2) HRP20191963T1 (zh)
HU (2) HUE048361T2 (zh)
IT (1) ITMI20130354A1 (zh)
LT (2) LT2964215T (zh)
PL (2) PL2964215T3 (zh)
PT (2) PT2964215T (zh)
RS (2) RS59523B1 (zh)
SI (2) SI2964215T1 (zh)
WO (1) WO2014135529A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130354A1 (it) 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
CN106714792A (zh) * 2014-08-08 2017-05-24 R·米利亚乔 用于治疗炎症性和过敏性病理学的脂肪酸和十六酰胺乙醇的混合物
AR102008A1 (es) * 2015-09-24 2017-01-25 Brix S R L Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
WO2019231281A1 (ko) * 2018-05-31 2019-12-05 재단법인 아산사회복지재단 폐섬유증의 예방 또는 치료를 위한 스테아르산의 용도
KR102204097B1 (ko) * 2019-01-31 2021-01-18 동신대학교 산학협력단 지방산을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물
WO2021163186A1 (en) * 2020-02-12 2021-08-19 Retrotope, Inc. Deuterated polyunsaturated fatty acids or esters thereof for cosmetic applications
AU2022328181A1 (en) * 2021-08-09 2024-03-21 Kentucky Equine Research, Inc. Compositions and methods for modulating equine fatty acid profiles
WO2023097296A1 (en) * 2021-11-24 2023-06-01 Jenivision Inc. Delivery methods for treating brain and central nervous system diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY24246A1 (es) 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
DE10161729A1 (de) 2001-12-15 2003-06-18 Mira Ursic Medizinische bzw. pharmazeutische Salbenzubereitung
EP1358872B1 (de) 2002-04-30 2008-03-12 Cognis IP Management GmbH Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
EP1617830A4 (en) * 2003-03-20 2008-09-24 Imagenetix Inc ESTERIFIED FATTY ACID COMPOSITION
US20080057552A1 (en) * 2006-08-31 2008-03-06 Inmok Lee Processes for Producing Fats or Oils and Compositions Comprising the Fats or Oils
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
JP4512881B2 (ja) * 2007-11-27 2010-07-28 築 中島 薬用油脂
US8765661B2 (en) * 2008-03-20 2014-07-01 Virun, Inc. Compositions containing non-polar compounds
US20090264520A1 (en) 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US8372425B2 (en) 2008-10-31 2013-02-12 Lipid Pharmaceuticals Ehf. Fatty acids for use as a medicament
WO2010118761A1 (en) 2009-04-17 2010-10-21 Eolas Science Limited Compositions rich in omega-3 fatty acids with a low content in phytanic acid
PT2796129E (pt) 2009-09-07 2015-10-13 Epitech Group S P A Composição contendo palmitoiletanolamida ultramicronizada
CA2703532C (en) 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
MX2013007884A (es) 2011-01-07 2013-09-13 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
ITMI20130354A1 (it) 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

Also Published As

Publication number Publication date
SI3219316T1 (sl) 2020-07-31
EA201791885A1 (ru) 2018-01-31
ES2753257T3 (es) 2020-04-07
HUE046239T2 (hu) 2020-02-28
RS59523B1 (sr) 2019-12-31
EA201591680A1 (ru) 2015-12-30
US20160015666A1 (en) 2016-01-21
EA035091B1 (ru) 2020-04-27
AU2018202190B2 (en) 2019-05-02
HUE048361T2 (hu) 2020-08-28
WO2014135529A1 (en) 2014-09-12
DK2964215T3 (da) 2019-11-11
EP3219316B1 (en) 2020-02-19
PL2964215T3 (pl) 2020-03-31
DK3219316T3 (da) 2020-03-16
CA2904112C (en) 2021-03-23
HRP20200394T1 (hr) 2020-06-12
LT3219316T (lt) 2020-04-10
CA2904112A1 (en) 2014-09-12
AU2014224710B2 (en) 2018-04-12
AU2018202190A1 (en) 2018-04-26
PT3219316T (pt) 2020-03-27
EP2964215B1 (en) 2019-08-21
PT2964215T (pt) 2019-11-12
AU2014224710A1 (en) 2015-09-10
RS60023B1 (sr) 2020-04-30
EP3219316A1 (en) 2017-09-20
CY1122783T1 (el) 2021-05-05
SI2964215T1 (sl) 2019-12-31
ITMI20130354A1 (it) 2014-09-09
US20210290578A1 (en) 2021-09-23
HRP20191963T1 (hr) 2020-01-24
ES2779851T3 (es) 2020-08-20
US11020365B2 (en) 2021-06-01
EA036724B1 (ru) 2020-12-11
EP2964215A1 (en) 2016-01-13
CY1122248T1 (el) 2020-11-25
PL3219316T3 (pl) 2020-06-01
LT2964215T (lt) 2019-11-25

Similar Documents

Publication Publication Date Title
HK1243924A1 (zh) 用於治療炎症病理的脂肪酸(f.a.g.，脂肪酸族)混合物
Upson et al. Where are all the female geniuses?
PL2984076T3 (pl) Estry i etery 2,5-tetrahydrofuranu jako plastyfikatory
PL3139770T3 (pl) Kompozycja kwasów tłuszczowych, sposób jej wytwarzania i jej zastosowanie
ZA201602970B (en) Process for the preparation of iopamidol
IL244755A0 (en) process to create xanthohumol
HK1254896A1 (zh) 鯨蠟脂肪酸、其製備系統及其應用
PL2964607T3 (pl) Sposób wytwarzania halogeno-n,n-dimetylobenzyloamin
EP3093285A4 (en) Gadolinium complex comprising do3a-tranexamic acid conjugate
Mighton For the love of math
SG11201608898UA (en) Unsaturated fatty acid absorption accelerator
SI3083976T1 (sl) Postopek priprave tiakumicina B
GB201316635D0 (en) Masterhitch hooker quick hitch
GB201310891D0 (en) The Universal Alchemical Egg